Class 2 Medicines Recall: Seretide Accuhaler

Class 2 Medicines Recall: Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed.

Glaxo Wellcome UK Limited is recalling one lot of Seretide Accuhaler 50/250mcg because a manufacturing issue has resulted in a small number of units not delivering the full number of doses. (EL (18) A/04)

Click here for further information on this alert.

GSK is also recalling two specific batches of Ventolin (salbutamol) 200mcg Accuhaler devices.

This action follows a manufacturing issue that may result in a small number of Accuhaler devices not delivering the full number of doses in the device.

The Accuhaler, which has a distinctive disk-like shape, is used to treat asthma, but is not widely used in the UK compared to the more commonly used Evohaler

Guidance to help patients identify if their Ventolin Accuhaler is affected by this recall and how to obtain a replacement is provided here.

No other GSK inhalers are affected by this issue, The more commonly used ‘boot’-shaped Ventolin Evohaler ‘rescue’ inhaler is not affected by this recall.

 

Recommended

Cycling on prescription rolls out in Cardiff

Pharmacy closures harm statin adherence in US study




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.